Hinge Health to acquire Cylinder Health, expanding into gastrointestinal care

The acquisition accelerates Hinge Health’s entry into one of healthcare’s largest underserved categories, with an integrated Gastrointestinal Care Program expected to launch in 2027.

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced that it has signed a definitive agreement to acquire Cylinder Health, Inc, a leader in virtual-first digestive healthcare, for $105 million in cash consideration. With this acquisition, Hinge Health intends to launch an integrated Gastrointestinal (GI) Care Program to complement its existing Musculoskeletal (MSK) and Migraine Care Programs.

GI conditions affect roughly one in four U.S. adults and drive $135 billion in annual medical spend, yet care remains fragmented and difficult to access. Symptoms can be ongoing and disruptive, and 69% of U.S. counties lack a gastroenterologist. As a result, people often cycle through primary and urgent care visits without a clear treatment plan.

“We’re entering GI care because of member and client demand,” said Daniel Perez, Co-Founder and CEO of Hinge Health. “Many people we already serve for back, joint, pelvic, and migraine care also have chronic digestive conditions. After spending time with Terry Boch and the Cylinder team, it’s clear that Cylinder gives us a running start in a category with significant unmet need.”

With nearly 100 clients across two million lives, partnerships with two of the three largest PBMs, and three of the top five health plans by self-insured market share, Cylinder has already treated over 150,000 people with a clinically-validated ROI. The acquisition will combine Cylinder’s clinical expertise and existing market footprint with Hinge Health’s AI-powered care model and technology platform to deliver support in a single app expected to launch in 2027.

“GI care is a growing need across our member population,” said Jessica Palacios, Associate Director, System Benefits Administration at The Texas A&M University System. “Our members engage with Hinge Health across multiple condition areas, so adding GI care within that same experience is a natural extension of a partnership that is already working and that our members trust.”

“GI conditions are highly comorbid with the conditions Hinge Health treats, sharing gut-brain and central-sensitization mechanisms,” said Hau Liu, MD, Chief Medical Officer of Cylinder Health. “This makes GI a strong fit for Hinge Health's technology-driven care model, and we look forward to delivering unified care to our combined members.”

The acquisition is subject to customary closing conditions. It is expected to close in the third quarter of 2026.

About Hinge Health

Hinge Health’s vision is to scale and automate the delivery of health care. Leveraging an AI-powered care model, connected hardware and access to expert clinicians, Hinge Health delivers personalized, evidence-based care that improves member outcomes and experiences while reducing costs for clients. The company is headquartered in San Francisco, California.

About FCA Venture Partners

FCA Venture Partners is a venture capital firm investing in companies transforming healthcare through innovative technology and services that improve patient outcomes, empower providers, lower costs, and redefine how care is delivered. FCA manages over $285 million and invests across the Series Seed to Series B stages.

FCA brings portfolio companies valuable healthcare insights, connections, and board-level experience to accelerate growth and build disruptive and sustainable businesses. Based in Nashville and Charlotte, the FCA team has a decades-long track record including more than 60 investments in the rapidly changing healthcare industry.

‍